Pfizer CEO Bourla Says Company Looking For 'Superior' Results from Weight-Loss Drugs

Pfizer CEO Albert Bourla told Bloomberg's Katie Greifeld Pfizer is looking for 'superior results' while developing and testing further GLP-1 weight loss medications in a crowded market. Bourla also commented on his company's relationship with the Trump administration as businesses look for stability...

Redirecting to full article...